Patent Applications published on Nov 25, 2010 - page 12

#3301
US20100296992A1
Performing operations; transporting

Honeycomb Catalyst And Catalytic Reduction Method

#3302 ✅ Patent 8,048,392 granted on 2011-11-01
US20100296993A1
Performing operations; transporting

Method for the cleaning of off-gas

#3303
US20100296994A1
Performing operations; transporting

CATALYST AND METHOD FOR DISMUTATION OF HALOSILANES CONTAINING HYDROGEN

#3304 ✅ Patent 8,894,961 granted on 2014-11-25
US20100296995A1
Chemistry; metallurgy

Sodium cyanide process

#3305 ✅ Patent 8,333,947 granted on 2012-12-18
US20100296996A1
Performing operations; transporting

Method of manufacturing carbon nanotubes

#3306 ✅ Patent 8,333,949 granted on 2012-12-18
US20100296997A1
Chemistry; metallurgy

Method for creating high carbon content products from biomass oil

#3307
US20100296998A1
Performing operations; transporting

REACTOR FOR PRODUCING CHLORINE AND PROCESS FOR PRODUCING CHLORINE

#3308
US20100296999A1
Chemistry; metallurgy

Ozonated capacitive deionization process

#3309
US20100297000A1
Chemistry; metallurgy

Product water from an ozonated capacitive deionization process

#3310 ✅ Patent 9,011,813 granted on 2015-04-21
US20100297001A1
Chemistry; metallurgy

Method and system for producing integrated hydrogen from organic matter

#3311 ✅ Patent 8,623,508 granted on 2014-01-07
US20100297002A1
Chemistry; metallurgy

Crystallized silicon-containing material with hierarchical and organized porosity

#3312 ✅ Patent 7,989,171 granted on 2011-08-02
US20100297003A1
Chemistry; metallurgy

Anti-human tenascin monoclonal antibody

#3313 ✅ Patent 8,940,298 granted on 2015-01-27
US20100297004A1
Chemistry; metallurgy

High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection

#3314 ✅ Patent 7,968,090 granted on 2011-06-28
US20100297005A1
Chemistry; metallurgy

Nucleic acids and corresponding proteins entitled 191P4D12(b) useful in treatment and detection of cancer

#3315
US20100297006A1
Chemistry; metallurgy

NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 191P4D12(b) USEFUL IN TREATMENT AND DETECTION OF CANCER

#3316 ✅ Patent 9,468,607 granted on 2016-10-18
US20100297007A1
Human necessities

Ligand directed toroidal nanoparticles for therapy and diagnostic imaging

#3317 ✅ Patent 8,758,753 granted on 2014-06-24
US20100297008A1
Chemistry; metallurgy

Ganglioside associated recombinant antibodies and the use thereof in the treatment of tumors

#3318
US20100297009A1
Chemistry; metallurgy

SELF-ASSEMBLED POLYHEDRAL MULTIMERIC CHEMICAL STRUCTURES

#3319
US20100297010A1
Chemistry; metallurgy

TUMOR SUPPRESSOR GENE SCREENING USING RNA INTERFERENCE LIBRARIES AND METHOD OF TREATMENT

#3320 ✅ Patent 8,906,383 granted on 2014-12-09
US20100297011A1
Chemistry; metallurgy

T cell receptor having binding affinity for a peptide-MHC complex and uses thereof

#3321
US20100297012A1
Chemistry; metallurgy

HUMANIZED ANTIBODY

#3322
US20100297013A1
Chemistry; metallurgy

HUMANIZED ANTIBODY

#3323
US20100297014A1
Physics

METHOD OF DETECTING THE RISK OF CANCER USING GENETIC MARKERS

#3324
US20100297015A1
Physics

CANCER BIOMARKER AND USES THEREOF

#3325 ✅ Patent 8,338,602 granted on 2012-12-25
US20100297016A1
Chemistry; metallurgy

Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids

#3326
US20100297017A1
Human necessities

Method for Synthesizing and Using Pegylated Peptide-Photoactive Chromophore Conjugates and Micellular Formulations Thereof

#3327 ✅ Patent 8,415,117 granted on 2013-04-09
US20100297018A1
Physics

Prognosis and therapy of liver failure

#3328 ✅ Patent 9,446,150 granted on 2016-09-20
US20100297019A1
Human necessities

Particles for imaging

#3329
US20100297020A1
Human necessities

PHOSPHORYLATED AND PHOSPHONATED PYRONE ANALOGS FOR THERAPEUTIC TREATMENT

#3330 ✅ Patent 8,198,242 granted on 2012-06-12
US20100297021A1
Chemistry; metallurgy

Variants of C-type natriuretic peptide

#3331 ✅ Patent 9,556,238 granted on 2017-01-31
US20100297022A1
Chemistry; metallurgy

Magnetosome gene expression in eukaryotic cells

#3332
US20100297023A1
Chemistry; metallurgy

Lipid

#3333 ✅ Patent 8,541,566 granted on 2013-09-24
US20100297024A1
Human necessities

Promoter inducible by reactive oxygen species and vector comprising the same

#3334
US20100297025A1
Human necessities

Novel compositions magnetic particles covered with gem-bisphosphonate derivatives

#3335
US20100297026A1
Human necessities

Imaging of Activated Vascular Endothelium Using Immunomagnetic MRI Contrast Agents

#3336
US20100297027A1
Human necessities

Overt authentication features for compositions and objects and methods of fabrication and verification thereof

#3337
US20100297028A1
Human necessities

MEDICAMENT COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES

#3338 ✅ Patent 9,603,361 granted on 2017-03-28
US20100297029A1
Human necessities

Virucidal composition

#3339
US20100297030A1
Human necessities

Composition, device, and method for treating sexual dysfunction via inhalation

#3340 ✅ Patent 9,623,010 granted on 2017-04-18
US20100297031A1
Human necessities

Orodispersible tablets

#3341
US20100297032A1
Human necessities

TRANSDERMAL DELIVERY SYSTEM

#3342
US20100297033A1
Human necessities

Megaribavirin alone or combination of other antiviral, antioxidant and a perflubron emulsion for treatment of viral disease

#3343
US20100297034A1
Human necessities

OSMOLYTE-CONTAINING PREPARATION FOR USE IN CASE OF DRY MUCOUS MEMBRANES

#3344
US20100297035A1
Chemistry; metallurgy

Thiazole Amides, Imidazole Amides and Related Analogues

#3345
US20100297036A1
Human necessities

PRESSURIZED COSMETIC COMPOSITION COMPRISING AT LEAST ONE ANIONIC POLYURETHANE ELASTOMER AND AT LEAST ONE PROPELLANT

#3346
US20100297037A1
Human necessities

MATERIAL COMPOSITION FOR ORAL HYGIENE PRODUCT

#3347
US20100297038A1
Chemistry; metallurgy

Benzimidazole Derivatives And Their Use As Cooling Agents

#3348
US20100297039A1
Human necessities

Oil-In-Water Emulsion Composition And Method For Producing The Same

#3349
US20100297040A1
Human necessities

Cellular age advantage; nutrient reservoir cosmetic composition

#3350
US20100297041A1
Human necessities

STABLE DISPERSIONS OF SOLID PARTICLES IN A HYDROPHOBIC SOLVENT AND METHODS OF PREPARING THE SAME

#3351
US20100297042A1
Human necessities

Cosmetic Compositions and Methods Comprising Rhodiola Rosea

#3352 ✅ Patent 8,586,011 granted on 2013-11-19
US20100297043A1
Human necessities

Skin coating composition and uses thereof

#3353
US20100297044A1
Human necessities

Emulsifier Mixture Containing Fatty Alcohols, Ethoxylated Fatty Alcohols and Oil or Wax Components

#3354 ✅ Patent 11,299,636 granted on 2022-04-12
US20100297045A1
Chemistry; metallurgy

Effect pigments based on artificially produced substrates with a narrow size distribution

#3355
US20100297046A1
Human necessities

Compositions and Methods Related to Fructosamine-3-Kinase Inhibitors

#3356
US20100297047A1
Chemistry; metallurgy

ESTERS OF GLYCEROL AND THEIR USES IN COSMETIC AND PHARMACEUTICAL APPLICATIONS

#3357 ✅ Patent 8,247,447 granted on 2012-08-21
US20100297048A1
Human necessities

Use of derivatives of 4-hydroxyphenoxy acetic acid

#3358 ✅ Patent 8,029,577 granted on 2011-10-04
US20100297049A1
Human necessities

Lightening and/or dyeing of human keratin fibres via a composition comprising a particular amino silicon compound and composition and device

#3359 ✅ Patent 8,697,039 granted on 2014-04-15
US20100297050A1
Human necessities

Compositions containing silicone polymer, wax and volatile solvent

#3360
US20100297051A1
Human necessities

COSMETIC COMPOSITION COMPRISING AT LEAST ONE ELASTOMERIC ANIONIC POLYURETHANE AND AT LEAST ONE NON-IONIC THICKENER

#3361
US20100297052A1
Human necessities

COSMETIC COMPOSITION COMPRISING AT LEAST ONE ELASTOMERIC POLYURETHANE

#3362
US20100297053A1
Textiles; paper

DEODERANT AND DEODERIZING PRODUCT

#3363 ✅ Patent 8,486,977 granted on 2013-07-16
US20100297054A1
Chemistry; metallurgy

1,2,3-triazole derivatives for use as stearoyl-CoA desaturase inhibitors

#3364
US20100297055A1
Human necessities

COSMETIC COMPOSITION COMPRISING MULTIFUNCTIONALISED POLY (ALPHA OLEFIN-COPOLYMER-MALEIC ANHYDRIDE)

#3365
US20100297056A1
Human necessities

COMPOSITION BASED ON PERHYDROSQUALENE AND COLLAGEN-POLYVINYLPYRROLIDONE FOR FILLING MINOR CUTANEOUS DEPRESSIONS

#3366 ✅ Patent 8,796,476 granted on 2014-08-05
US20100297057A1
Human necessities

Pesticide compositions exhibiting enhanced activity and methods for preparing same

#3367 ✅ Patent 8,246,943 granted on 2012-08-21
US20100297058A1
Human necessities

Prebiotic composition

#3368
US20100297059A1
Human necessities

METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, LYMANRIA DISPAR

#3369
US20100297060A1
Chemistry; metallurgy

ENHANCEMENT OF ANTIBODY-CYTOKINE FUSION PROTEIN MEDIATED IMMUNE RESPONSES BY COMBINED TREATMENT WITH IMMUNOCYTOKINE UPTAKE ENHANCING AGENTS

#3370
US20100297061A1
Chemistry; metallurgy

STAT3 ANTAGONISTS AND THEIR USES AS VACCINES AGAINST CANCER

#3371 ✅ Patent 8,323,634 granted on 2012-12-04
US20100297062A1
Human necessities

Stable formulations of highly concentrated recombinant human albumin-human granulocyte colony stimulating factor

#3372
US20100297063A1
Chemistry; metallurgy

CYTOKINE ZALPHA11 LIGAND ANTIBODIES

#3373 ✅ Patent 7,998,468 granted on 2011-08-16
US20100297064A1
Chemistry; metallurgy

Cytokine zalpha11 ligand antibodies

#3374
US20100297065A1
Chemistry; metallurgy

HOMOGENEOUS PREPARATIONS OF IL-31

#3375 ✅ Patent 8,974,776 granted on 2015-03-10
US20100297066A1
Human necessities

Biodegradable peptide releasing polymers

#3376
US20100297067A1
Chemistry; metallurgy

METHYLATION MARKERS FOR PROSTATE CANCER AND METHODS OF USE

#3377
US20100297068A1
Human necessities

METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29

#3378
US20100297069A1
Human necessities

PEGYLATED INTERLEUKIN-10

#3379 ✅ Patent 9,550,827 granted on 2017-01-24
US20100297070A1
Chemistry; metallurgy

Methods for ameliorating and preventing central nervous system inflammation

#3380 ✅ Patent 9,504,737 granted on 2016-11-29
US20100297071A1
Human necessities

Immune response inducer

#3381
US20100297072A1
Human necessities

Combinations of Immunostimulatory Agents, Oncolytic Virus, and Additional Anticancer Therapy

#3382
US20100297073A1
Chemistry; metallurgy

HETEROCYCLIC ANTIVIRAL COMPOUNDS

#3383
US20100297074A1
Human necessities

Wound healing compositions, systems, and methods

#3384
US20100297075A1
Human necessities

COMBINATIONAL COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER

#3385 ✅ Patent 9,139,634 granted on 2015-09-22
US20100297076A1
Human necessities

Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities

#3386 ✅ Patent 8,202,513 granted on 2012-06-19
US20100297077A1
Chemistry; metallurgy

Aryl potassium channel blockers and uses thereof

#3387
US20100297078A1
Chemistry; metallurgy

METHOD FOR PRODUCING A HYDROXYALKYL STARCH DERIVATIVE WITH TWO LINKERS

#3388
US20100297079A1
Human necessities

COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTION

#3389 ✅ Patent 8,535,887 granted on 2013-09-17
US20100297080A1
Chemistry; metallurgy

Genetic markers associated with interferon-alpha response

#3390
US20100297081A1
Human necessities

PHARMACEUTICAL FORMULATION CONTAINING RECOMBINANT HUMAN SERUM ALBUMIN-INTERFERON ALPHA FUSION PROTEIN

#3391
US20100297082A1
Human necessities

WEIGHT-BEARING POLYURETHANE COMPOSITES AND METHODS THEREOF

#3392 ✅ Patent 8,101,736 granted on 2012-01-24
US20100297083A1
Chemistry; metallurgy

Polynucleotides and polypeptide of human KV1.3, compositions comprising same and methods of using same

#3393 ✅ Patent 10,696,983 granted on 2020-06-30
US20100297084A1
Chemistry; metallurgy

Method for transducing cells with primary cilia

#3394 ✅ Patent 8,586,028 granted on 2013-11-19
US20100297085A1
Chemistry; metallurgy

Synthetic herpes simplex viruses type-1 for treatment of cancers

#3395 ✅ Patent 9,320,795 granted on 2016-04-26
US20100297086A1
Human necessities

Bacteriophage preparations and methods of use thereof

#3396
US20100297087A1
Chemistry; metallurgy

PLURIPOTENT STEM CELLS CHARACTERIZED BY EXPRESSION OF GERMLINE SPECIFIC GENES

#3397 ✅ Patent 8,728,819 granted on 2014-05-20
US20100297088A1
Chemistry; metallurgy

Methods for culturing minimally-passaged fibroblasts and uses thereof

#3398 ✅ Patent 8,491,885 granted on 2013-07-23
US20100297089A1
Chemistry; metallurgy

Method for promoting the self-renewal of adult stem cells using mesenchymal stromal cells

#3399
US20100297090A1
Chemistry; metallurgy

HEMATOPOIETIC CELL CULTURE NUTRIENT SUPPLEMENT

#3400
US20100297091A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATMENT OF MELANOMAS

#3401 ✅ Patent 8,568,743 granted on 2013-10-29
US20100297092A1
Human necessities

Inactivated bacterial cell formulation

#3402
US20100297093A1
Chemistry; metallurgy

MODIFIED T CELL RECEPTORS AND RELATED MATERIALS AND METHODS

#3403
US20100297094A1
Human necessities

THERAPY OR PREVENTION OF DISEASES WITH CELLS OR CELL SUPERNATANT

#3404 ✅ Patent 8,383,100 granted on 2013-02-26
US20100297095A1
Human necessities

Method to treat and prevent skin diseases with Porifera-based therapeutic compositions treating and preventing skin diseases

#3405 ✅ Patent 9,457,056 granted on 2016-10-04
US20100297096A1
Human necessities

Peptides comprising alternating hydrophobic and anionic amino acids for treatment of osteoporosis

#3406 ✅ Patent 8,207,204 granted on 2012-06-26
US20100297097A1
Chemistry; metallurgy

Triazole derivatives as SCD inhibitors

#3407 ✅ Patent 8,383,776 granted on 2013-02-26
US20100297098A1
Human necessities

Purification of factor XIII polypeptides from biological materials

#3408
US20100297099A1
Human necessities

Airway Administration of Activated Protein C in Inflammatory Conditions Affecting the Respiratory Tract

#3409 ✅ Patent 8,372,811 granted on 2013-02-12
US20100297100A1
Human necessities

Composition for treating retinopathy or glaucoma comprising thrombin derived peptides

#3410 ✅ Patent 8,586,033 granted on 2013-11-19
US20100297101A1
Chemistry; metallurgy

Integrin αβspecific antibodies and peptides

#3411
US20100297102A1
Physics

SEROTONIN 5-HT3A RECEPTORS IN TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS

#3412
US20100297103A1
Chemistry; metallurgy

ANTIBODY HAVING ENHANCED ADCC ACTIVITY AND METHOD FOR PRODUCTION THEREOF

#3413 ✅ Patent 8,609,900 granted on 2013-12-17
US20100297104A1
Chemistry; metallurgy

Dendritic macromolecule and a process thereof

#3414 ✅ Patent 9,347,061 granted on 2016-05-24
US20100297105A1
Chemistry; metallurgy

Administering antisense oligonucleotides complementary to human apolipoprotein B

#3415 ✅ Patent 8,383,114 granted on 2013-02-26
US20100297106A1
Human necessities

Pharmaceutical formulations

#3416
US20100297107A1
Chemistry; metallurgy

HMGB1 PROTEIN INHIBITORS AND/OR ANTAGONISTS FOR THE TREATMENT OF VASCULAR DISEASES

#3417 ✅ Patent 9,370,531 granted on 2016-06-21
US20100297108A1
Human necessities

Method of providing patient specific immune response in amyloidoses and protein aggregation disorders

#3418
US20100297109A1
Human necessities

METHODS FOR INHIBITING FASCIN

#3419
US20100297110A1
Chemistry; metallurgy

ANTIBODY SPECIFIC FOR HUMAN IL-4 FOR THE TREATMENT OF CANCER

#3420 ✅ Patent 8,703,131 granted on 2014-04-22
US20100297111A1
Physics

Nanobodies against tumor necrosis factor-alpha

#3421
US20100297112A1
Human necessities

COMBINATIONS COMPRISING DMXAA FOR THE TREATMENT OF CANCER

#3422 ✅ Patent 9,089,605 granted on 2015-07-28
US20100297113A1
Human necessities

Quinone derivatives, pharmaceutical compositions, and uses thereof

#3423 ✅ Patent 8,961,991 granted on 2015-02-24
US20100297114A1
Chemistry; metallurgy

Anti-CD40 targeted fusion proteins

#3424
US20100297115A1
Chemistry; metallurgy

USE OF TRKB ANTIBODIES FOR THE TREATMENT OF RESPIRATORY DISORDERS

#3425
US20100297116A1
Chemistry; metallurgy

USES OF A GLYCOPROTEIN VI (GPVI) INHIBITOR

#3426 ✅ Patent 8,796,206 granted on 2014-08-05
US20100297117A1
Human necessities

Aqueous formulation of erythropoiesis stimulating protein stabilised by antioxidants for parenteral administration

#3427
US20100297118A1
Human necessities

Therapeutic Cancer Treatments

#3428
US20100297119A1
Chemistry; metallurgy

BONE TARGETED ALKALINE PHOSPHATASE, KITS AND METHODS OF USE THEREOF

#3429 ✅ Patent 9,365,634 granted on 2016-06-14
US20100297120A1
Chemistry; metallurgy

Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues

#3430
US20100297121A1
Human necessities

Methods for Treating Pressure Induced Optic Neuropathy, Preventing Neuronal Degeneration and Promoting Neuronal Cell Survival Via Administration of LINGO-1 Antagonists and TrkB Agonists

#3431 ✅ Patent 8,637,021 granted on 2014-01-28
US20100297122A1
Chemistry; metallurgy

Formulations for TACI-immunoglobulin fusion proteins

#3432
US20100297123A1
Chemistry; metallurgy

COMBINATION THERAPY TO INHIBIT T CELL EFFECTOR FUNCTION

#3433 ✅ Patent 8,420,620 granted on 2013-04-16
US20100297124A1
Chemistry; metallurgy

Induced internalization of surface receptors

#3434 ✅ Patent 7,943,132 granted on 2011-05-17
US20100297125A1
Chemistry; metallurgy

Methods of treating pain using antagonists of IL-31, IL-31RA and/or OSMRB

#3435 ✅ Patent 8,444,986 granted on 2013-05-21
US20100297126A1
Chemistry; metallurgy

Monoclonal antibodies specific to hemagglutinin from influenza virus H5-subtype and uses thereof

#3436
US20100297127A1
Chemistry; metallurgy

USE OF IL-27 ANTAGONISTS TO TREAT LUPUS

#3437 ✅ Patent 8,426,595 granted on 2013-04-23
US20100297128A1
Chemistry; metallurgy

Gamma secretase modulators

#3438 ✅ Patent 8,119,134 granted on 2012-02-21
US20100297129A1
Chemistry; metallurgy

Method for extending pregnancy in patients exhibiting at least one symptom of preeclampsia and eclampsia

#3439 ✅ Patent 8,101,406 granted on 2012-01-24
US20100297130A1
Chemistry; metallurgy

Protective anti-glucan antibodies with preference for β-1,3-glucans

#3440 ✅ Patent 8,252,293 granted on 2012-08-28
US20100297131A1
Chemistry; metallurgy

Binding domain of reticulocyte binding proteins

#3441
US20100297132A1
Chemistry; metallurgy

Monoclonal antibody

#3442 ✅ Patent 8,337,846 granted on 2012-12-25
US20100297133A1
Chemistry; metallurgy

Immunogenic polypeptides and monoclonal antibodies

#3443 ✅ Patent 8,470,320 granted on 2013-06-25
US20100297134A1
Chemistry; metallurgy

Humanised antibodies with anti-tumour activity

#3444
US20100297135A1
Chemistry; metallurgy

EPITOPE FOR NEUTRALIZING ANTIBODIES

#3445
US20100297136A1
Chemistry; metallurgy

Gastric and Prostate Cancer Associated Antigens

#3446
US20100297137A1
Physics

Hematopoietic Lineage Cell Specific Protein (HS1) as a Marker for Lymphoid Malignancy

#3447 ✅ Patent 8,383,118 granted on 2013-02-26
US20100297138A1
Chemistry; metallurgy

Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM1

#3448 ✅ Patent 9,345,739 granted on 2016-05-24
US20100297139A1
Human necessities

Methods and compositions for the treatment of proteinuric diseases

#3449
US20100297140A1
Chemistry; metallurgy

USES OF ANTIBODIES

#3450 ✅ Patent 9,095,539 granted on 2015-08-04
US20100297141A1
Human necessities

Anti-adhesin based passive immunoprophylactic

#3451 ✅ Patent 8,518,872 granted on 2013-08-27
US20100297142A1
Human necessities

Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-OXO-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid in combination therapy

#3452 ✅ Patent 9,051,368 granted on 2015-06-09
US20100297143A1
Chemistry; metallurgy

Methods for treating psoriasis by administering an antibody which binds an epitope of the p40 subunit of IL-12 and/or IL-23

#3453 ✅ Patent 9,149,517 granted on 2015-10-06
US20100297144A1
Human necessities

Multitype HPV peptide compositions and methods for treatment or prevention of human papillomavirus infection

#3454
US20100297145A1
Human necessities

Apoptosis promoter, cell proliferation inhibitor, prophylactic/therapeutic agent for cancer, screening method for the promoter, inhibitor or agent

#3455
US20100297146A1
Chemistry; metallurgy

IMMUNE SYSTEM PROGRAMMING THROUGH B7-DC

#3456
US20100297147A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR MODULATING TLR14 ACTIVITY

#3457 ✅ Patent 8,084,035 granted on 2011-12-27
US20100297148A1
Chemistry; metallurgy

CD38 modulated chemotaxis

#3458 ✅ Patent 8,404,242 granted on 2013-03-26
US20100297149A1
Chemistry; metallurgy

Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities

#3459
US20100297150A1
Human necessities

DISEASE TREATMENT VIA ANTIMICROBIAL PEPTIDE INHIBITORS

#3460 ✅ Patent 8,143,385 granted on 2012-03-27
US20100297151A1
Chemistry; metallurgy

Nucleic acids coding for antibodies against human IL-21 receptor and uses therefor

#3461
US20100297152A1
Chemistry; metallurgy

METHODS OF DIAGNOSIS OF PROSTATE CANCER, COMPOSITIONS AND METHODS OF SCREENING FOR MODULATORS OF PROSTATE CANCER

#3462 ✅ Patent 8,551,488 granted on 2013-10-08
US20100297153A1
Chemistry; metallurgy

Binding molecules for treatment and detection of cancer

#3463
US20100297154A1
Human necessities

CD40 ligand-enhanced cells and methods of modulating an immune response to an antigen

#3464 ✅ Patent 8,313,771 granted on 2012-11-20
US20100297155A1
Chemistry; metallurgy

Phosphazene hydrogels with chemical corss-link, preparation method thereof and use thereof

#3465
US20100297156A1
Chemistry; metallurgy

ANALOGUES OF PHOSPHATIDYLINOSITOL MANNOSIDES

#3466
US20100297157A1
Human necessities

VACCINE THERAPY FOR CHOROIDAL NEOVASCULARIZATION

#3467 ✅ Patent 8,211,436 granted on 2012-07-03
US20100297158A1
Physics

Anticancer vaccine and diagnostic methods and reagents

#3468
US20100297159A1
Chemistry; metallurgy

THOMSEN-FRIEDENREICH DISACCHARIDE MODIFIED IMMUNOGEN (TFD), PREPARATION PROCEDURE, COMPOSITIONS COMPRISING IT, USES, AND TREATMENT METHODS

#3469
US20100297160A1
Human necessities

High Molecular Weight Amyloid Beta As a Carrier for the Oral Delivery of Vaccine Antigens

#3470 ✅ Patent 7,993,652 granted on 2011-08-09
US20100297161A1
Chemistry; metallurgy

Immunoprotective influenza antigen and its use in vaccination

#3471 ✅ Patent 8,236,325 granted on 2012-08-07
US20100297162A1
Human necessities

antigens

#3472 ✅ Patent 8,318,185 granted on 2012-11-27
US20100297163A1
Human necessities

Recombinant malaria vaccine

#3473 ✅ Patent 8,481,057 granted on 2013-07-09
US20100297164A1
Human necessities

Chlamydial antigens

#3474 ✅ Patent 9,421,254 granted on 2016-08-23
US20100297165A1
Human necessities

Immunostimulatory combinations of TLR ligands and methods of use

#3475 ✅ Patent 8,129,147 granted on 2012-03-06
US20100297166A1
Human necessities

Meningococcal oligosaccharide linked polysaccharides and diptheria protein conjugate vaccine for all ages

#3476 ✅ Patent 8,828,687 granted on 2014-09-09
US20100297167A1
Human necessities

Method for the production of recombinant virus, DNA constructs, recombinant virus and vaccine compositions

#3477 ✅ Patent 8,420,104 granted on 2013-04-16
US20100297168A1
Chemistry; metallurgy

Lentiviral gene transfer vectors and their medicinal applications

#3478 ✅ Patent 8,652,486 granted on 2014-02-18
US20100297169A1
Human necessities

Neutralizing immunogen (NimIV) of rhinovirus and its use for vaccine applications

#3479 ✅ Patent 8,784,837 granted on 2014-07-22
US20100297170A1
Human necessities

Vaccines comprising an immunostimulatory peptide and an immunostimulatory oligodeoxynucleic acid molecule

#3480 ✅ Patent 8,106,026 granted on 2012-01-31
US20100297171A1
Chemistry; metallurgy

Development of a preventive vaccine for filovirus infection in primates

#3481 ✅ Patent 8,592,205 granted on 2013-11-26
US20100297172A1
Chemistry; metallurgy

Replication-defective arenavirus vectors

#3482 ✅ Patent 7,892,555 granted on 2011-02-22
US20100297173A1
Human necessities

Prophylactic and therapeutic immunization against protozoan infection and disease

#3483 ✅ Patent 9,051,359 granted on 2015-06-09
US20100297174A1
Human necessities

Influenza virus vaccines and uses thereof

#3484 ✅ Patent 8,063,195 granted on 2011-11-22
US20100297175A1
Human necessities

Mutations in a toll-like receptor motif in the NS4B of classical swine fever virus strain brescia influences virulence in swine

#3485 ✅ Patent 8,303,965 granted on 2012-11-06
US20100297176A1
Human necessities

Polyinosinic acid-polycytidylic acid-based adjuvant

#3486
US20100297177A1
Physics

MUTATED PARVOVIRUS STRUCTURAL PROTEINS AS VACCINES

#3487
US20100297178A1
Chemistry; metallurgy

NOVEL GENES AND PROTEINS OF BRACHYSPIRA HYODYSENTERIAE AND USE OF SAME FOR DIAGNOSIS AND THERAPY

#3488
US20100297179A1
Human necessities

Immunology Treatment for Biofilms

#3489
US20100297180A1
Human necessities

BOTULINUM NEUROTOXIN VACCINE

#3490
US20100297181A1
Human necessities

AMPA Receptor Antagonists for Epilepsy, Mental Disorders or Deficits in Sensory Organ

#3491
US20100297182A1
Human necessities

Injectable Amino-acid Composition

#3492
US20100297183A1
Physics

IMMUNOGENIC STREPTOCOCCUS PROTEINS

#3493 ✅ Patent 8,187,610 granted on 2012-05-29
US20100297184A1
Human necessities

strain

#3494 ✅ Patent 8,394,388 granted on 2013-03-12
US20100297185A1
Chemistry; metallurgy

Mycobacterial mutants affecting host apoptosis

#3495 ✅ Patent 8,900,598 granted on 2014-12-02
US20100297186A1
Human necessities

Multicomponent or monocomponent vaccine to be used against Chagas disease, pharmaceutical compositions containing them, procedure for the obtention of immunogen of said vaccines, and nucleic acid used in said procedure

#3496 ✅ Patent 8,986,703 granted on 2015-03-24
US20100297187A1
Chemistry; metallurgy

Peptide sequences and compositions

#3497 ✅ Patent 8,637,037 granted on 2014-01-28
US20100297188A1
Human necessities

Allergens and allergoids from bee venom

#3498 ✅ Patent 9,345,754 granted on 2016-05-24
US20100297189A1
Human necessities

Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine

#3499
US20100297190A1
Performing operations; transporting

IDENTIFICATION FEATURES

#3500 ✅ Patent 9,381,141 granted on 2016-07-05
US20100297191A1
Human necessities

Method for manufacturing a cleansing and/or care article

#3501
US20100297192A1
Chemistry; metallurgy

USE OF MICROPARTICLES FOR VACCINES AND THE RELEASE OF BIOLOGICALLY ACTIVE MOLECULES

#3502 ✅ Patent 8,784,897 granted on 2014-07-22
US20100297193A1
Human necessities

Methods of therapeutic treatment of eyes

#3503
US20100297194A1
Human necessities

FORMULATION FOR ORAL ADMINISTRATION OF APOPTOSIS PROMOTER

#3504
US20100297195A1
Human necessities

CONTROLLED RELEASE LAMOTRIGINE FORMULATIONS

#3505 ✅ Patent 8,114,903 granted on 2012-02-14
US20100297196A1
Chemistry; metallurgy

Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids

#3506 ✅ Patent 9,066,889 granted on 2015-06-30
US20100297197A1
Human necessities

Non-fluoride containing dietary supplement toothpaste and methods of using the same

#3507
US20100297198A1
Human necessities

LIQUID-TYPE DENTIFRICE COMPOSITION CONTAINED SILVER PARTICLES AND MOUSSE-TYPE DENTIFRICE USING THE SAME

#3508 ✅ Patent 8,465,757 granted on 2013-06-18
US20100297199A1
Human necessities

Nanoemulsion of resveratrol-phospholipid complex and method for preparing the same and applications thereof

#3509 ✅ Patent 8,399,005 granted on 2013-03-19
US20100297200A1
Human necessities

Use of nitric oxide to enhance the efficacy of silver and other topical wound care agents

#3510 ✅ Patent 9,327,143 granted on 2016-05-03
US20100297201A1
Human necessities

Use of polyelectrolyte complexes in antiperspirant technology

#3511
US20100297202A1
Human necessities

PLANAR ANTENNA AND METHOD OF MANUFACTURING THE SAME

#3512 ✅ Patent 8,252,269 granted on 2012-08-28
US20100297203A1
Human necessities

Impact of calcium phosphate complex on dental caries

#3513
US20100297204A1
Human necessities

PARTICULATE POLYMERS COMPRISING BIOCIDAL ACTIVE SUBSTANCE

#3514 ✅ Patent 8,241,660 granted on 2012-08-14
US20100297205A1
Human necessities

Patch for the expulsion of insect poison from the skin after stings from membranous insects (hymenoptera)

#3515
US20100297206A1
Human necessities

Antimicrobial Upconversion System

#3516 ✅ Patent 8,853,454 granted on 2014-10-07
US20100297207A1
Human necessities

Quaternary ammonium salts as microbe inhibitors

#3517 ✅ Patent 8,338,402 granted on 2012-12-25
US20100297208A1
Chemistry; metallurgy

Scaffold

#3518
US20100297209A1
Human necessities

SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES

#3519
US20100297210A1
Human necessities

REPAIR AND TREATMENT OF BONE DEFECT USING AGENT PRODUCED BY CHONDROCYTES CAPABLE OF HYPERTROPHICATION AND SCAFFOLD

#3520 ✅ Patent 7,879,953 granted on 2011-02-01
US20100297211A1
Chemistry; metallurgy

Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents

#3521
US20100297212A1
Human necessities

SCAFFOLD FOR CELL GROWTH AND DIFFERENTIATION

#3522
US20100297213A1
Performing operations; transporting

Method For Making Patches By Electrospray

#3523
US20100297214A1
Human necessities

PERCOLATIVE DRYING FOR THE PREPARATION OF PARTICLES

#3524 ✅ Patent 8,461,136 granted on 2013-06-11
US20100297215A1
Human necessities

Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy

#3525
US20100297216A1
Human necessities

METHOD FOR ADMINISTRATION OF PEGYLATED LIPOSOMAL DOXORUBICIN

#3526 ✅ Patent 8,624,057 granted on 2014-01-07
US20100297217A1
Chemistry; metallurgy

Isoprenoid compounds, their isolation and use

#3527
US20100297218A1
Human necessities

TISSUE ADHESIVE COMPOSITIONS AND METHODS THEREOF

#3528
US20100297219A1
Chemistry; metallurgy

Methods and Compositions for Modifying Apolipoprotein B mRNA Editing

#3529
US20100297220A1
Human necessities

Pharmaceutical Formulation And Method For Treating Acid-Caused Gastrointestinal Disorders

#3530 ✅ Patent 8,911,777 granted on 2014-12-16
US20100297221A1
Human necessities

Pharmaceutical composition of tacrolimus

#3531 ✅ Patent 8,496,968 granted on 2013-07-30
US20100297222A1
Performing operations; transporting

Method for production of microcapsules using solid fat

#3532
US20100297223A1
Human necessities

PHARMACEUTICAL DOSAGE FORM COMPRISING A LIQUID OR FLOWABLE CORE COMPOSITION

#3533
US20100297224A1
Human necessities

NSAID Dose Unit Formulations with H2-Receptor Antagonists and Methods of Use

#3534
US20100297225A1
Human necessities

SUSTAINED-RELEASE PHARMACEUTICAL FORMULATION CONTAINING AN ANTIMUSCARINIC AGENT AND A WETTING AGENT AS WELL AS A PROCESS FOR THE PREPARATION THEREOF

#3535
US20100297226A1
Human necessities

MULTIPLE UNIT PHARMACEUTICAL FORMULATION

#3536 ✅ Patent 8,753,681 granted on 2014-06-17
US20100297227A1
Human necessities

Pharmaceutical composition comprising at least one active agent and a binder, which swells in an acidic media

#3537
US20100297228A1
Performing operations; transporting

UNIVERSAL COATING FOR IMPRINTING IDENTIFICATION FEATURES

#3538
US20100297229A1
Human necessities

TAPENTADOL COMPOSITIONS

#3539
US20100297230A1
Human necessities

COMPOSITIONS AND METHODS FOR PROSTATE AND MENSTRUAL/MENOPAUSAL RELATED HEALTH

#3540 ✅ Patent 8,617,576 granted on 2013-12-31
US20100297231A1
Chemistry; metallurgy

Preservation of bioactive materials by freeze dried foam

#3541
US20100297232A1
Human necessities

ONDANSETRON FILM COMPOSITIONS

#3542 ✅ Patent 9,217,129 granted on 2015-12-22
US20100297233A1
Chemistry; metallurgy

Oscillating cell culture bioreactor

#3543
US20100297234A1
Chemistry; metallurgy

METHOD OF USING AN EXTRACELLULAR MATRIX TO ENHANCE CELL TRANSPLANT SURVIVAL AND DIFFERENTIATION

#3544
US20100297235A1
Human necessities

Vascular puncture closure systems, devices, and methods using biocompatible synthetic hydrogel compositions

#3545
US20100297236A1
Human necessities

HYBRID INDUCIBLE RELEASE VEHICLE

#3546 ✅ Patent 9,233,078 granted on 2016-01-12
US20100297237A1
Human necessities

Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer

#3547 ✅ Patent 8,338,390 granted on 2012-12-25
US20100297238A1
Human necessities

Multifunctional and biologically active matrices from multicomponent polymeric solutions

#3548
US20100297239A1
Chemistry; metallurgy

OSSEOINTEGRATIVE MENISCUS AND CARTILAGE IMPLANTS BASED ON BETA-GLUCAN NANOCOMPOSITES

#3549 ✅ Patent 8,722,684 granted on 2014-05-13
US20100297240A1
Human necessities

1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment

#3550
US20100297241A1
Chemistry; metallurgy

Amorphous Fesoterodine Fumarate

#3551
US20100297242A1
Human necessities

LDL-LIKE CATIONIC NANOPARTICLES FOR DELIVERYING NUCLEIC ACID GENE, METHOD FOR PREPARING THEREOF AND METHOD FOR DELIVERYING NUCLEIC ACID GENE USING THE SAME

#3552
US20100297243A1
Human necessities

PRION FREE NANOPARTICLE COMPOSITIONS AND METHODS OF MAKING THEREOF

#3553 ✅ Patent 8,586,062 granted on 2013-11-19
US20100297244A1
Human necessities

Nanodispersion

#3554 ✅ Patent 8,936,786 granted on 2015-01-20
US20100297245A1
Human necessities

Methods and compositions for oral administration of protein and peptide therapeutic agents

#3555
US20100297246A1
Human necessities

SILICA-BASED NANOPARTICLES AND METHODS OF STIMULATING BONE FORMATION AND SUPPRESSING BONE RESORPTIOIN THROUGH MODULATION OF NF-KB

#3556 ✅ Patent 9,522,121 granted on 2016-12-20
US20100297247A1
Human necessities

Aqueous-core lipid nanocapsules for encapsulating hydrophilic and/or lipophilic molecules

#3557
US20100297248A1
Performing operations; transporting

ENCAPSULATED PARTICLES FOR AMORPHOUS STABILITY ENHANCEMENT

#3558
US20100297249A1
Human necessities

ENHANCEMENT OF THE EFFICACY OF THERAPEUTIC PROTEINS

#3559 ✅ Patent 8,133,515 granted on 2012-03-13
US20100297250A1
Chemistry; metallurgy

Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds

#3560
US20100297251A1
Performing operations; transporting

ENCAPSULATED PARTICLES FOR ENTERIC RELEASE

#3561
US20100297252A1
Human necessities

NANOPARTICULATE MELOXICAM FORMULATIONS

#3562 ✅ Patent 8,710,003 granted on 2014-04-29
US20100297253A1
Chemistry; metallurgy

Treatment of diabetes with milk protein hydrolysate

#3563 ✅ Patent 8,431,169 granted on 2013-04-30
US20100297254A1
Human necessities

Nutraceutical composition and methods of use

#3564 ✅ Patent 8,282,953 granted on 2012-10-09
US20100297255A1
Human necessities

Malleable implants containing demineralized bone matrix

#3565
US20100297256A1
Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR INHIBITING INTEGRINS USING TELLURIUM-CONTAINING COMPOUNDS

#3566
US20100297257A1
Human necessities

ANTICOAGULANT ANTAGONIST AND HEMOPHILLIA PROCOAGULANT

#3567
US20100297258A1
Chemistry; metallurgy

Treatment of burns

#3568
US20100297259A1
Human necessities

PESTICIDE COMPOSITIONS EXHIBITING ENHANCED ACTIVITY

#3569 ✅ Patent 8,785,379 granted on 2014-07-22
US20100297260A1
Human necessities

Pesticide compositions exhibiting enhanced activity

#3570
US20100297261A1
Human necessities

Food Product and Fortification System Therefor

#3571
US20100297262A1
Human necessities

PHARMACEUTICALLY ACTIVE COMPOSITIONS COMPRISING OXIDATIVE STRESS MODULATORS (OSM), NEW CHEMICAL ENTITIES, COMPOSITIONS AND USES

#3572
US20100297263A1
Human necessities

COLON CLEANSING COMPOSITIONS AND METHODS

#3573
US20100297264A1
Human necessities

BOWEL PURGATIVE AND USES THEREOF

#3574
US20100297265A1
Human necessities

Optimal compositions and methods for treating oral disease and pain

#3575 ✅ Patent 8,993,005 granted on 2015-03-31
US20100297266A1
Human necessities

Food compositions comprising lemon balm extracts

#3576 ✅ Patent 7,947,313 granted on 2011-05-24
US20100297267A1
Human necessities

Compositions for diabetes treatment and prophylaxis

#3577
US20100297268A1
Human necessities

AGENT FOR INCREASING BLOOD ADIPONECTIN QUANTITY

#3578 ✅ Patent 8,202,550 granted on 2012-06-19
US20100297269A1
Human necessities

Compositions for intranasal administration

#3579
US20100297270A1
Human necessities

COMPOSITION FOR TREATMENT OF ISCHEMIC HEART DISEASE, FACILITATION OF BLOOD CIRCULATION AND ANGIOGENESIS, IMPROVING SKIN BEAUTY, IMPROVING MALE SEXUAL FUNCTION CONTAINING GINSENG BERRY EXTRACT

#3580 ✅ Patent 9,149,424 granted on 2015-10-06
US20100297271A1
Human necessities

Compositions and methods for reducing hepatotoxicity associated with drug administration

#3581 ✅ Patent 8,501,246 granted on 2013-08-06
US20100297272A1
Human necessities

Cosmetic composition containing lingonberry extract and its uses

#3582 ✅ Patent 9,283,173 granted on 2016-03-15
US20100297273A1
Human necessities

Emulsified wax compositions and uses thereof

#3583 ✅ Patent 8,765,191 granted on 2014-07-01
US20100297274A1
Human necessities

Cocoa extracts for use in providing skin benefits

#3584 ✅ Patent 8,500,435 granted on 2013-08-06
US20100297275A1
Performing operations; transporting

Positioning device

#3585 ✅ Patent 8,480,389 granted on 2013-07-09
US20100297276A1
Human necessities

Spacer mold and methods therefor

#3586
US20100297277A1
Performing operations; transporting

Extrusion Device

#3587 ✅ Patent 8,939,750 granted on 2015-01-27
US20100297278A1
Performing operations; transporting

Strand pelletizer

#3588
US20100297279A1
Performing operations; transporting

EXTENDED NIP EMBOSSING APPARATUS

#3589
US20100297280A1
Performing operations; transporting

EXTENDED NIP EMBOSSING APPARATUS

#3590
US20100297281A1
Performing operations; transporting

EXTENDED NIP EMBOSSING APPARATUS

#3591 ✅ Patent 8,845,320 granted on 2014-09-30
US20100297282A1
Physics

Imprint lithography apparatus

#3592 ✅ Patent 8,007,271 granted on 2011-08-30
US20100297283A1
Performing operations; transporting

Injection nozzle, in particular hot-runner nozzle, for arrangement in an injection mould

#3593
US20100297284A1
Performing operations; transporting

CASTING MOLD DEVICE

#3594
US20100297285A1
Performing operations; transporting

Pipe Body Extrusion Device

#3595
US20100297286A1
Performing operations; transporting

HIGH PRESSURE EMBOSSING APPARATUS

#3596 ✅ Patent 8,202,081 granted on 2012-06-19
US20100297287A1
Performing operations; transporting

Mould cavity with decoupled cooling-channel routing

#3597 ✅ Patent 8,529,971 granted on 2013-09-10
US20100297288A1
Performing operations; transporting

Packaging of a stack of confectionery pellets and the like

#3598
US20100297289A1
Human necessities

Composition for Stabilising a Dietary Aqueous Liquid Sensitive to Oxidation

#3599
US20100297290A1
Chemistry; metallurgy

ALTERNATIVE METHOD FOR RUM PRODUCTION REDUCING POLLUTION AND BYPASSING UPGRADE OF POLLUTION CONTROLS

#3600
US20100297291A1
Physics

VISIBLE/NEAR-INFRARED SPECTRUM ANALYZING METHOD AND GRAPE FERMENTING METHOD